Regenesance presenting on BioCapital Europe. March 26, 2015.
EPIC Biotech, October 2015
Regenesance presenting on EPIC Biotech. October 8, 2015.
Stichting ALS Nederland to invest in Regenesance and become a shareholder.
Regenesance antibody fully characterized and ready for production.
Regenesance CSO Frank Baas to present at the 3rd meeting of the Belgian-Dutch Neuromuscular Study Club.
Regenesance leading scientist Dr. Valeria Ramaglia to give a presentation at the Annual Traumatic Brain Injury Conference in Washington.
Regenesance Patent estate granted further allowence in different countries.